Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy.

Abumiya, Maiko; Takahashi, Naoto; Takahashi, Saori; Yoshioka, Tomoko; Kameoka, Yoshihiro; Miura, Masatomo

Abumiya, Maiko; Takahashi, Naoto; Takahashi, Saori; Yoshioka, Tomoko; Kameoka, Yoshihiro; Miura, Masatomo.

Affiliation

Abumiya M; Department of Pharmacy, Akita University Hospital, 1-1-1 Hondo, Akita, 010-8543, Japan.
Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
Takahashi S; Clinical Research Promotion and Support Center, Akita University Hospital, Akita, Japan.
Yoshioka T; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
Kameoka Y; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
Miura M; Clinical Research Promotion and Support Center, Akita University Hospital, Akita, Japan.

Sci Rep ; 11(1): 6362, 2021 03 18.

Article in En | MEDLINE | ID: mdl-33737618

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Biomarkers, Pharmacological / Organic Cation Transporter 2 / Aniline Compounds / Nitriles Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google